Frequency-dependent acceleration of cardiac repolarization by progesterone underlying its cardiac protection against drug-induced proarrhythmic effects in female rabbits.
Concurrent supplement of estradiol and progesterone has been shown to reduce the cardiac sensitivity to class III antiarrhythmic agent-induced arrhythmias in ovariectomized rabbits. To understand the underlying cardiac electrophysiological mechanisms of the hormones, present study explored the modulation of progesterone and estradiol on repolarization and its frequency dependence in papillary muscles of female rabbit right ventricles by glass microelectrode technique. Results showed that progesterone shortened action potential duration for 90% repolarization (APD(90)) whereas estradiol prolonged APD(90) and those actions on APD(90) were concentration-dependent for both hormones at 1.0-30 μM (P<0.05 or P<0.01). Further, the action of both hormones on APD(90) was found to be dependent on stimulation frequencies (0.2-3.3Hz). The shortening of APD(90) by progesterone (10 μM) was enhanced with the increase in frequencies reaching a statistic significance at frequencies ≥1.0 Hz, whereas the prolongation of APD(90) by estradiol (3 μM) was weakened with the increase in frequencies and the significant change was observed at frequencies ≤2.0 Hz (P<0.05 or P<0.01). More interestingly, the relative change of APD(90) and the incidence of early afterdepolarization induced after by dofetilide (0.1 μM), a class III antiarrhythmic agent, were significantly less or lower in the papillary muscles pretreated with progesterone than in those pretreated with estradiol (P<0.01 or P<0.05). In conclusion, progesterone has a reverse modulating affect on cardiac repolarization to that of estradiol. By acceleration of ventricular repolarization, progesterone may reduce the susceptibility of females to class III antiarrhythmic agents-induced proarrhythmic affection.
Department of Pharmacology, School of Medicine, Tongji University, Shanghai 200092, China. jcheng@tongji.edu.cn
Jianhua
J
Cheng
Juan
J
Zhang
Xiaohong
X
Ma
Dan
D
Su
D000200:Action Potentials / Q000187:drug effects* / Q000502:physiology; D000818:Animals; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000503:physiopathology / Q000517:prevention & control*; D002316:Cardiotonic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004562:Electrocardiography / Q000187:drug effects; D004958:Estradiol / Q000633:toxicity*; D005260:Female; D009924:Organ Culture Techniques; D010210:Papillary Muscles / Q000187:drug effects / Q000502:physiology; D011374:Progesterone / Q000494:pharmacology / Q000627:therapeutic use*; D011817:Rabbits
D002316:Cardiotonic Agents; D011374:Progesterone; D004958:Estradiol